Feasibilty of FDG-PET/CT for response monitoring of the axilla in breast cancer patients.

被引：0
|
作者：
Straver, M. E. [1 ]
Aukema, T. S. [1 ]
Olmos, R. A. Valdes [1 ]
Rutgers, E. J. T. [1 ]
Gilhuijs, K. G. A. [1 ]
Vogel, W. V. [1 ]
Peeters, M. T. F. D. Vrancken [1 ]
机构：
[1] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S163 / S163
页数：1
相关论文
共 50 条
  • [31] Clinical significance of FDG-PET/CT at the postoperative surveillance in the breast cancer patients
    Na Young Jung
    Ie Ryung Yoo
    Bong Joo Kang
    Sung Hun Kim
    Byung Joo Chae
    Ye Young Seo
    [J]. Breast Cancer, 2016, 23 : 141 - 148
  • [32] Percentage of reduction in FDG-PET/CT imaging biomarkers as a predictor for pathological response in breast cancer patients
    Abd El-Gaid, Salwa
    Elahmadawy, Mai
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [33] 18F-FDG PET/CT for monitoring treatment response in bone-dominant metastatic breast cancer patients.
    Portilla Merino, P.
    Escabias del Pozo, C.
    Abadi Sedraoui, Y.
    Lopez Llobet, E.
    Giraldo Gonzalez, L.
    Rizkallal Monzon, S.
    Monachello Araujo, D.
    Lancha Hernandez, C.
    Rodado Marina, S.
    Coronado Poggio, M.
    Cordero Garcia, J.
    Dominguez Gadea, L.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S481 - S481
  • [34] FDG-PET/CT for systemic staging of patients with newly diagnosed breast cancer
    David Groheux
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1417 - 1419
  • [35] FDG-PET/CT for Assessing the Response to Neoadjuvant Chemotherapy in Bladder Cancer Patients
    Soubra, Ayman
    Gencturk, Mehmet
    Froelich, Jerry
    Balaji, Priya
    Gupta, Shilpa
    Jha, Gautam
    Konety, Badrinath R.
    [J]. CLINICAL GENITOURINARY CANCER, 2018, 16 (05) : 360 - 364
  • [36] Assessment of hormonal therapy response using FDG-PET/CT in metastatic breast cancer
    Mortazavi-Jehanno, N.
    Giraudet, A. L.
    Edeline, V.
    Banayan, S.
    Madar, O.
    Tubiana, M.
    Pecking, A. P.
    Alberini, J. L.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S176 - S176
  • [37] Breast cancer: treatment response assessment with FDG-PET/CT in the neoadjuvant and in the metastatic setting
    David Groheux
    Gary A. Ulaner
    Elif Hindie
    [J]. Clinical and Translational Imaging, 2023, 11 : 439 - 452
  • [38] Breast cancer: treatment response assessment with FDG-PET/CT in the neoadjuvant and in the metastatic setting
    Groheux, David
    Ulaner, Gary A.
    Hindie, Elif
    [J]. CLINICAL AND TRANSLATIONAL IMAGING, 2023, 11 (05) : 439 - 452
  • [39] Initial experience with FDG-PET/CT in the evaluation of breast cancer
    Mitsuaki Tatsumi
    Christian Cohade
    Karen A. Mourtzikos
    Elliot K. Fishman
    Richard L. Wahl
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 254 - 262
  • [40] Integrated FDG-PET/CT for initial staging of breast cancer
    Khan, Q. J.
    O'Dea, A. P.
    Dusing, R.
    Sharma, P.
    Roling, S. M.
    Fabian, C. J.
    Kimler, B. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345